Literature DB >> 2189999

Interferon alpha-2a and dacarbazine in melanoma.

J M Kirkwood1, M S Ernstoff, A Giuliano, R Gams, W A Robinson, J Costanzi, P Pouillart, J Speyer, M Grimm, R Spiegel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2189999     DOI： 10.1093/jnci/82.12.1062

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  4 in total

Review 1.  Current treatment options for malignant melanoma.

Authors:  G L Cohen; C I Falkson
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

2.  Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma.

Authors:  C I Falkson
Journal:  Med Oncol       Date:  1995-03       Impact factor: 3.064

Review 3.  Systemic treatments for metastatic cutaneous melanoma.

Authors:  Sandro Pasquali; Andreas V Hadjinicolaou; Vanna Chiarion Sileni; Carlo Riccardo Rossi; Simone Mocellin
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

Review 4.  WITHDRAWN: Chemoimmunotherapy versus chemotherapy for metastatic malignant melanoma.

Authors:  Andre D Sasse; Emma C Sasse; Luciana Go Clark; Otavio Augusto Camara Clark
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.